Last reviewed · How we verify
Placebo to match Tolebrutinib
Placebo to match Tolebrutinib is a Small molecule drug developed by Sanofi. It is currently in Phase 3 development.
This is a placebo formulation designed to match the appearance, taste, and administration characteristics of Tolebrutinib for blinded clinical trial purposes.
At a glance
| Generic name | Placebo to match Tolebrutinib |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo comparators in clinical trials are inert formulations manufactured to be indistinguishable from the active drug in Phase 3 studies. They contain no active pharmaceutical ingredient and serve as the control arm to assess the true efficacy and safety of the investigational agent relative to no pharmacological intervention.
Approved indications
Common side effects
Key clinical trials
- Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) (PHASE3)
- Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis (PHASE3)
- Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) (PHASE3)
- Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) (PHASE3)
- Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo to match Tolebrutinib CI brief — competitive landscape report
- Placebo to match Tolebrutinib updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about Placebo to match Tolebrutinib
What is Placebo to match Tolebrutinib?
How does Placebo to match Tolebrutinib work?
Who makes Placebo to match Tolebrutinib?
What development phase is Placebo to match Tolebrutinib in?
Related
- Manufacturer: Sanofi — full pipeline
- Compare: Placebo to match Tolebrutinib vs similar drugs
- Pricing: Placebo to match Tolebrutinib cost, discount & access